Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

January 17, 2022

Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.

Journal of Alzheimer's Disease : JAD
Mingjing LiuWeihong Song
January 17, 2022

Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.

Journal of Alzheimer's Disease : JAD
Guillermo EastmanJosé R Sotelo-Silveira
January 17, 2022
Review

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.

Trends in Neurosciences
Vinod UdayarRavi Jagasia
January 17, 2022
Open Access

Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains.

Molecular Neurodegeneration
Tarin M BigleyDavid M Holtzman
January 16, 2022
Preprint
Open Access

Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in an Alzheimer's disease model

BioRxiv : the Preprint Server for Biology
H. ZengXiao Wang
January 16, 2022
Review

N6-methyladenosine and Neurological Diseases.

Molecular Neurobiology
Nan ZhangLielian Zuo
January 16, 2022

Postmortem brain 7T MRI with minimally invasive pathological correlation in deceased COVID-19 subjects.

Insights Into Imaging
Maria da Graça Morais MartinAmaro Nunes Duarte-Neto
January 15, 2022
Open Access

Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells.

Oxidative Medicine and Cellular Longevity
Qingqi MengHaifeng Zhang
January 14, 2022
Review

On-going consequences of in utero exposure of Pb: An epigenetic perspective.

Journal of Applied Toxicology : JAT
Fahim Rejanur TasinChanchal Mandal
January 13, 2022
Preprint
Open Access

Bulk and Single-nucleus Transcriptomics Highlight Intra-telencephalic and Somatostatin Neurons in Alzheimer's Disease

BioRxiv : the Preprint Server for Biology
M. E. ConsensD. Felsky
January 13, 2022
Review

Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.

Neural Regeneration Research
Alejandro R RodaSandra Villegas
January 13, 2022

ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression.

ACS Chemical Neuroscience
Alfred J Robison, Eric J Nestler
January 12, 2022
Review
Open Access

MiR-155: An Important Regulator of Neuroinflammation.

International Journal of Molecular Sciences
Valeria Domenica ZingaleEmanuela Mazzon
January 12, 2022
Review

Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Md Mominur RahmanMd Sahab Uddin
January 12, 2022

[Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
J XueJ Fan
January 12, 2022

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology.

Nature Communications
Zoeb JiwajiGiles E Hardingham

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-transcription/59381bb2-c649-4d20-a018-bdc1da706b86